We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Aaron Michels

Aaron W. Michels MD

Associate Professor of Pediatrics, Medicine, and Immunology; Director of Clinical Immunology, Barbara Davis Center; Frieda and George S. Eisenbarth Clinical Immunology Endowed Chair, University of Colorado Anschutz Medical Campus, Aurora, Colorado

Aaron Michels, MD, is a scientist and practicing endocrinologist at the Barbara Davis Center for Diabetes, which is part of the University of Colorado. He has lived with type 1 diabetes for more than two decades and is committed to caring for patients with diabetes along with conducting research to prevent and ultimately cure the disease. His research focuses on understanding the basic immunology of type 1 diabetes to design specific therapies to prevent and stop the autoimmune destruction of insulin producing cells. He has successfully translated his research findings from ‘bench to bedside’ with a personalized medicine drug in clinical trials to prevent the immune mediated destruction of pancreatic beta cells.

Disclosures

Dr. Michels has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Undertreatment of CV Risk Factors in Type 1 Diabetes